The Carlyle (CG.US) Price Target 2026/2027: 15% Upside + 2.9% Dividend

48,68
-2,34%
Price history for The Carlyle (CG.US) – stock price at 48.68 $, August 2026
The Carlyle stock price – price development 2026. Updated Aug 6, 2026.
Share this analysis:

The Carlyle Price Target 2026: Analysts See 14% Upside

The average price target for The Carlyle is $55.59. This price target represents the analysts' view of the stock price over the next 12 months. The stock may be undervalued, because the price target is higher than the current price. The stock is 14,21% below the target, which can point to potential returns within the next 12 months if the analysts' view proves right. Also consider the stock's valuation ratios such as P/E, P/S and P/B, plus the technical analysis further down the page, for the full picture.

Is The Carlyle overvalued or undervalued?

The Carlyle is currently undervalued with a gap of 14.2% relative to the price target.


The current price is $48.68, which places The Carlyle in the undervalued category. The stock is considered undervalued when the price is below $50.03, and overvalued when the price exceeds $61.15.


The fair value range is defined as ±10% of the price target, because price targets are estimates rather than exact values. For The Carlyle, the fair value range lies between $50.03 and $61.15.


See the full price target analysis for The Carlyle →

Analyst Ratings for The Carlyle stock in 2026: Buy

17 analysts cover The Carlyle. The ratings are mixed, with 47.1% Buy, 47.1% Hold and 5.9% Sell. The average price target is $55.59, which gives an upside of 14.2% from the current price.

Consensus: Buy (3.76/5)
Strong Buy
6 (35.3%)
Buy
2 (11.8%)
Hold
8 (47.1%)
Sell
1 (5.9%)
Strong Sell Sell Hold Buy Strong Buy
3.76 out of 5 based on 17 analysts

About The Carlyle – Asset Management

Carlyle Group er et investeringsfirma, som primært laver store opkøb af virksomheder, altså det, de kalder *Leveraged Buyouts*. De driver også en del strategiske minoritetsinvesteringer og struktureret kredit. Kort sagt tjener Carlyle Group penge på at købe, udvikle og sælge forretninger igen. De har delt deres forretning op i fire hovedområder: Corporate Private Equity, som er de store opkøb, Real Assets, som dækker ejendomme og infrastruktur, Global Market Strategies og Solutions. De investerer bredt, fra industri og energi til sundhedspleje og software. Carlyle Group blev stiftet i 1987 og er kendt for at lave handler inden for mange sektorer. De arbejder globalt og har kontorer i 26 lande. Read more about the company

Key Figures for The Carlyle

$ 17,6B Market cap
$ 3,2B Revenue
Asset Management Industry
32.67 P/E
5.86 P/S
3.07 P/B
USA Listed on exchange

What kind of stock is The Carlyle?

Dividend stock Growth stock

The Carlyle is classified as a dividend stock and growth stock. This means the stock combines several attractive traits, including a dividend of 2.9%.

Score Overview for The Carlyle

💰 Value Score 44/100 (Neutral)
⭐ Quality Score 45/100 (Neutral)
🚀 Momentum Score 40/100 (Neutral)
📊 Total Score 43/100

⚠️ 1 red flag identified

Our analysis has identified 1 potential risk factor in The Carlyle that investors should be aware of.

⚠️ High debt: The debt-to-equity ratio is 299% – the company carries considerably more debt than equity, which raises the financial risk.

📈 Valuation

The Carlyle trades at a P/E ratio of 32.7, which is above the market average. The forward P/E is 11.3 (65% lower), which suggests the market expects rising earnings. The P/S ratio is 5.9 (high — the market pays a premium for the revenue). The P/B ratio is 3.1. The PEG ratio is 1.00 — below 1.0 suggests the stock is cheap relative to its growth rate.

💵 Profitability & Growth

The Carlyle has a profit margin of 16.8% (solid). Return on equity (ROE) is 9.4%. Return on assets (ROA) is 2.4%. The latest quarterly earnings grew 70.2% year over year — strong growth.

🏦 Financial Health

The Piotroski score is 6 out of 9 — good financial health. The debt-to-equity ratio (D/E) is 298.8% — high debt, which raises the risk.

🚀 Momentum & Short Interest

Short interest is 6.03% — elevated, some investors are betting on a decline.

The Carlyle Dividend 2026: 2.9% Dividend Yield

Dividend Key Figures for The Carlyle in 2026

Dividend yield
2.86%
Dividend per share
0.35 USD
Payout ratio
49.0%
Healthy
Dividend growth (5 years)
+40.0%
Avg. annual dividend (3 years)
1.28 USD

When does The Carlyle pay a dividend in 2026?

Latest ex-dividend date (traded without the dividend)
May 18, 2026
Next dividend payment
May 28, 2026
Latest payment date
May 28, 2026

How much does The Carlyle pay in dividends?

The Carlyle pays dividends to its shareholders. The most recently paid dividend was 0.35 USD per share, which corresponds to a dividend yield of 2.86%. Over the last 5 years, the annual dividend has grown by 40.0%, which shows positive dividend growth.

The payout ratio is 49.0%, which is considered healthy and sustainable. The company balances rewarding shareholders with reinvesting in growth.

Historical Dividend Payments for The Carlyle

We have registered dividend payments for The Carlyle since 2020-05-11. In that period the stock has paid a dividend 32 times, most recently on 2026-05-18. This stock qualifies as a stable dividend stock, because it has paid a dividend at least once a year for the last 5 years. That makes it attractive to investors looking for steady, regular dividend payments.

Ex-datePayment dateAmountCurrencyPeriod
2026-05-182026-05-280.35USDUnknown period
2026-05-182026-05-280.35USDUnknown period
2026-05-182026-05-280.35USDUnknown period
2026-05-182026-05-280.35USDUnknown period
2026-05-182026-05-280.35USDUnknown period
2026-05-182026-05-280.35USDUnknown period
2026-05-182026-05-280.35USDUnknown period
2026-05-182026-05-280.35USDUnknown period
2026-05-182026-05-280.35USDUnknown period
2026-02-132026-02-200.35USDUnknown period
2025-11-102025-11-190.35USDUnknown period
2025-08-182025-08-280.35USDUnknown period
2025-02-212025-02-280.35USDUnknown period
2024-11-182024-11-250.35USDUnknown period
2024-08-162024-08-260.35USDUnknown period
2024-05-132024-05-210.35USDUnknown period
2024-02-222024-03-010.35USDUnknown period
2023-11-202023-11-290.35USDUnknown period
2023-08-142023-08-230.35USDUnknown period
2023-05-152023-05-230.35USDUnknown period
2023-02-212023-03-010.33USDUnknown period
2022-11-172022-11-250.33USDUnknown period
2022-08-082022-08-160.33USDUnknown period
2022-05-092022-05-170.33USDUnknown period
2022-02-142022-02-230.25USDUnknown period
2021-11-082021-11-170.25USDUnknown period
2021-08-092021-08-170.25USDUnknown period
2021-05-102021-05-190.25USDUnknown period
2021-02-122021-02-230.25USDUnknown period
2020-11-092020-11-170.25USDUnknown period
2020-08-102020-08-180.25USDUnknown period
2020-05-112020-05-190.25USDUnknown period

Insider Trading in The Carlyle 2026: The Signal Is negative

In 2026, insiders at The Carlyle have made 20 transactions – split into 2 purchases and 18 sales. On a net basis, insiders took 730,464,696 $ out of the stock. Active insiders include Rice Derica W, ORDAN MARK S, Redett John C. and others. In the short term (last 3 months), the insider signal is negative.

Short-Term Signal (3 months): Negative

Insiders have exclusively sold shares over the last 3 months.

Over the last 3 months: 0 purchases and 6 sales. A net 17,745,910 $ out of the stock.

Long-Term Signal (all transactions): Mostly negative

Insiders have sold considerably more than they have bought. At large companies this can be due to planned sales (10b5-1 plans) and is not necessarily a negative signal.

Across the last 20 transactions: 2 purchases and 18 sales. A net 730,464,696 $ out of the stock.

Latest purchase: Rice Derica W bought 4,450 shares at 49 $ each on 2026-05-01. The stock has since risen 0.8%.

Latest sale: Redett John C. sold 124,558 shares at 46 $ each on 2026-08-01.

Who is buying: Rice Derica W, ORDAN MARK S.

Who is selling: Redett John C., Plouffe Justin, Nedelman Jeffrey, LoBue Lindsay, Jenkins Mark David and others.

Latest Insider Trades in The Carlyle (2026)

The table shows the last 20 reported insider transactions in The Carlyle. Green rows are purchases, red rows are sales. The data is based on official filings.

Transaction date Name Type Number of shares Price per share ($) Total amount ($)
2026-08-01 Redett John C. Sell 124,558 46 5,732,159
2026-08-01 Plouffe Justin Sell 62,533 46 2,877,769
2026-08-01 Nedelman Jeffrey Sell 43,081 46 1,982,588
2026-08-01 LoBue Lindsay Sell 18,284 46 841,430
2026-08-01 Jenkins Mark David Sell 124,793 46 5,742,974
2026-08-01 Andrews Charles Elliott Jr. Sell 12,364 46 568,991
2026-05-01 Rice Derica W Buy 4,450 49 220,008
2026-05-01 ORDAN MARK S Buy 4,450 49 220,008
2026-03-19 Rubenstein David M. Sell 100,000 47 4,668,000
2026-03-19 David M Rubenstein Sell 500,000 47 23,340,000

Who is buying and selling The Carlyle shares in 2026?

The following insiders have bought shares in The Carlyle: Rice Derica W, ORDAN MARK S. In total, 440,016 $ was bought across 2 transactions. The following insiders have sold shares: Redett John C., Plouffe Justin, Nedelman Jeffrey, LoBue Lindsay, Jenkins Mark David and others. In total, 730,904,712 $ was sold across 18 transactions. Insider trades are legal transactions in which executives and board members buy or sell shares of their own company. These transactions are reported to the SEC and are publicly available.

The Carlyle Short Selling 2026: 6.0% Sold Short

High short interest: 6.0% of the free float
Short % of free float
6.0%
Assessment
High short interest
Short squeeze risk
Moderate
Data source
SEC
Updated daily
The stock has a high share of short selling. Between 5-10% of the freely traded shares are sold short, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze.

What does this mean for you as an investor?
A short interest of 6.0% means that 6.0% of the freely traded shares in The Carlyle have been borrowed and sold by investors betting on falling prices.

Data is updated daily based on official filings with the SEC.
Short Interest Scale
0% 2% 5% 10% 20%+
Low Moderate High Very High Extreme
6.0%

When Does The Carlyle Report Earnings?

The next earnings date for The Carlyle is not yet available. Check the company's investor calendar for more information.



Technical Analysis of The Carlyle 2026 – Signal: Hold

Overall Technical Signal: Hold

Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated August 6, 2026.

Technical analysis of The Carlyle (CG.US) – RSI 66, MACD positive (bullish), daily candlestick chart August 2026
The Carlyle technical analysis – candlestick chart with RSI and MACD. Updated Aug 6, 2026.

Trend Analysis of The Carlyle Group Inc

The Carlyle Group Inc is in a short-term uptrend. The price of $49.84 is 8.5% above the 20-day average ($45.94). Medium term, the picture is positive: the price is 11.4% above the 50-day average ($44.74). Long term, the stock is 2.6% below the 200-day average ($51.17), which signals a long-term downtrend.

Death Cross: The 50-day average (44.74) is below the 200-day average (51.17), which is a classic bearish signal for The Carlyle Group Inc.

Is The Carlyle Group Inc overbought or oversold?

The Carlyle Group Inc has an RSI of 65.6. The stock shows positive momentum in the upper part of the neutral zone.

MACD Analysis for The Carlyle Group Inc

Daily MACD: MACD is positive (1.138), which means the short-term trend is bullish (the 12-day EMA is above the 26-day EMA). MACD is above the signal line (0.579) by 0.559, which confirms rising momentum in the uptrend.

Weekly MACD: MACD5 is negative (-2.041), which indicates a broader bearish long-term trend. MACD5 is above the signal line (-2.490) by 0.449, which suggests the negative long-term momentum is fading – a bigger trend reversal could be ahead.

Overall MACD assessment: The daily and weekly MACD give conflicting signals. The short-term trend is bullish, but the long-term trend is still bearish. Weekly momentum is rising, though, which could signal an upcoming trend reversal.

Risk Profile for The Carlyle Group Inc

The Carlyle Group Inc has an annual standard deviation of 36.7%, which classifies the stock as medium risk. The price can swing noticeably when the market moves.

Overall Technical Conclusion for The Carlyle Group Inc

Trend: Neutral/mixed.

MACD trend (zero line): Daily bullish (1.138). Weekly bearish (-2.041).

MACD momentum (signal): Daily rising. Weekly rising.

RSI: 65.6 – neutral.

Technical signal: Hold

The signals are mixed – trend and MACD point in different directions. Wait until MACD crosses the zero line in the direction of the trend before acting.

Frequently Asked Questions About The Carlyle stock in 2026

Should you buy The Carlyle stock now?
The technical signal for The Carlyle is currently NEUTRAL. The Carlyle trades at $48.68 as of 8/6/2026. The overall technical signal is: Hold. The technical analysis shows the following: MACD is positive (bullish trend) at 1.138 with rising momentum (signal: 0.579); RSI is at 65.6 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $55.59 points to 14.2% upside. This is a technical observation based on current data, not investment advice.
What is the price target for The Carlyle stock?
The average analyst price target for The Carlyle is $55.59. The current price is $48.68, which gives an upside of 14.2%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $50.03 and $61.15.
Is The Carlyle a dividend stock?
Yes, The Carlyle is a dividend stock with a dividend yield of 2.86%. The latest dividend was $0.35 per share. The latest ex-dividend date (traded without the dividend) was 5/18/2026. The payout ratio is 49.0%, which is considered sustainable. The next dividend payment is scheduled for 5/28/2026.
When does The Carlyle pay a dividend in 2026?
The Carlyle pays its next dividend on 5/28/2026. The latest dividend was $0.35 per share with an ex-dividend date of 5/18/2026. The dividend yield is 2.86%. The payout ratio of 49.0% points to a sustainable dividend with room to grow.
What is the risk of The Carlyle stock?
The Carlyle is rated as a stock with moderate risk. the annual standard deviation is 36.7%, which classifies the stock as moderate risk.
Is The Carlyle overvalued?
No, The Carlyle is considered undervalued based on the analyst price target (14.2% upside). The Carlyle has the following valuation ratios: a P/E ratio of 32.7 (highly valued), a P/S ratio of 5.9, a P/B ratio of 3.1. The analyst price target suggests that the stock is undervalued by 14.2%.
Is The Carlyle overbought?
No, The Carlyle is not overbought. RSI is at 65.6 (neutral zone). The technical indicators show: RSI is at 65.6 (upper neutral zone), which shows positive momentum but is not yet overbought. In addition, the price is 6.0% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next The Carlyle earnings report?
The date of the next earnings report for The Carlyle has not been published yet. Check the company's investor calendar for updates.
Is The Carlyle shorted?
Yes, The Carlyle is shorted with 6.0% of the free float sold short. This is a high level of short selling, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze. Data is updated daily based on official filings with the SEC.
Are insiders buying The Carlyle stock?
No, insiders are not buying The Carlyle shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 6 sales. On a net basis, 17,745,910 $ worth of shares were sold. Across the last 20 reported transactions, the split is 2 purchases and 18 sales, with a net 730,464,696 $ sold. Active sellers include Redett John C., Plouffe Justin, Nedelman Jeffrey and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is The Carlyle a good stock?
Based on our total score, The Carlyle is rated as a mediocre stock with a total score of 43 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 44/100, Quality: 45/100, Momentum: 40/100. In addition: analysts see 14.2% upside to the price target; a dividend of 2.86%; technical signal: Hold. Whether The Carlyle is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for The Carlyle stock?
The outlook for The Carlyle based on current data: the average analyst price target is $55.59 (+14.2%); the P/E ratio is 32.7 (high – the market expects growth). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is The Carlyle stock rising?
The Carlyle is rising right now. The technical indicators show: the price is 6.0% above the 20-day average; MACD is positive with rising momentum (bullish signal); short interest is 6.0% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can The Carlyle go?
The average analyst price target for The Carlyle is $55.59, which corresponds to a potential gain of 14.2% from the current price of $48.68. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can The Carlyle fall?
We lack enough history to give a specific floor for The Carlyle. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does The Carlyle do?
Carlyle Group er et investeringsfirma, som primært laver store opkøb af virksomheder, altså det, de kalder *Leveraged Buyouts*. De driver også en del strategiske minoritetsinvesteringer og struktureret kredit. Kort sagt tjener Carlyle Group penge på at købe, udvikle og sælge f... The company belongs to the Financiel service sector, more specifically the Asset Management industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate The Carlyle as an investment.
Did The Carlyle raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from The Carlyle. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is The Carlyle making money or losing money?
Yes, The Carlyle is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 16.8% — which is solid. At a P/E ratio of 32.7, you currently pay 32.7 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can The Carlyle go bankrupt?
Altman Z2 is not used for banks and financial companies — their balance sheet is built on debt (that is the business model), so the model would wrongly classify a healthy bank as distressed. For The Carlyle, look instead at the capital base (e.g. the core capital ratio), loan losses and earnings power.
Does The Carlyle have a lot of debt?
Yes, The Carlyle has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 299%. For the financiel service sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can The Carlyle service its debt? Could struggle to service its debt — the interest coverage ratio (how many times earnings can cover interest payments) is -3.6x, and net debt equals 9.5 years of earnings (EBITDA).